APO RESEARCH · REPORT
Immobilized Trypsin
Immobilized Trypsin provides a fast and convenient method for digesting a range of concentrations of purified protein or complex protein mixtures. Digested peptides are easily separated from the Immobilized Trypsin as they flow through the spin column into the collection tube. Immobilized Trypsin is easily removed from the peptide solution because the trypsin does not pass though the column frit. Trypsin is a proteolytic enzyme, which cleaves at the carboxyl side of positively charged Lysine (Lys) and Arginine (Arg). When these amino acids are followed by the nonpolar Proline (Pro), the digestion of the site is not efficient. When Lys and Arg are followed by acids [Aspartic Acid (Asp) and Glutamic Acid (Glu)] the digestion is also not as efficient.
Product & engineering
Understand the product.
Immobilized Trypsin provides a fast and convenient method for digesting a range of concentrations of purified protein or complex protein mixtures. Digested peptides are easily separated from the Immobilized Trypsin as they flow through the spin column into the collection tube. Immobilized Trypsin is easily removed from the peptide solution because the trypsin does not pass though the column frit. Trypsin is a proteolytic enzyme, which cleaves at the carboxyl side of positively charged Lysine (Lys) and Arginine (Arg). When these amino acids are followed by the nonpolar Proline (Pro), the digestion of the site is not efficient. When Lys and Arg are followed by acids [Aspartic Acid (Asp) and Glutamic Acid (Glu)] the digestion is also not as efficient.
Selected research
Market Structure
Global Immobilized Trypsin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Immobilized Trypsin provides a fast and convenient method for digesting a range of concentrations of purified protein or complex protein mixtures. Digested peptides are easily separated from the Immobilized Trypsin as they flow through the spin column into the collection tube. Immobilized Trypsin is easily removed from the peptide solution because the trypsin does not pass though the column frit. Trypsin is a proteolytic enzyme, which cleaves at the carboxyl side of positively charged Lysine (Lys) and Arginine (Arg). When these amino acids are followed by the nonpolar Proline (Pro), the digestion of the site is not efficient. When Lys and Arg are followed by acids [Aspartic Acid (Asp) and Glutamic Acid (Glu)] the digestion is also not as efficient.
North American is the largest consumption place, with a consumption market share nearly 45% in 2019. Following North American, Europe is the second with the market share of 28.39%.
Market competition is intense. Promega, Thermo Scientific, G-Biosciences, SignalChem and Takara, etc. are the leaders of the industry, and they hold key patents, with high-end customers. Top 5 occupied 3/5 of the market in 2019.
Read the full market overview
According to the form, the classification of Immobilized Trypsin includes 2 ml, 4ml, etc. In addition, the proportion of 2 ml in 2019 is about 70.63%.
Immobilized Trypsin is widely used for Academic & Research Institutes and Pharmaceutical Companies. The most proportion of Immobilized Trypsin is used for Academic & Research Institutes, and the proportion in 2019 is about 62.15%.
This report provides an overview of the global Immobilized Trypsin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Immobilized Trypsin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Immobilized Trypsin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immobilized Trypsin market size, projected growth trends, production technologies, key applications, and end-use industries.
Immobilized Trypsin Segment by Company
Promega
Thermo Scientific
G-Biosciences
SignalChem
Takara
GoldBio
Creative Enzymes
ProteoChem
Immobilized Trypsin Segment by Type
2 ml
4 ml
Others
Immobilized Trypsin Segment by Application
Academic & Research Institutes
Pharmaceutical Companies
Immobilized Trypsin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immobilized Trypsin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immobilized Trypsin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immobilized Trypsin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Immobilized Trypsin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immobilized Trypsin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immobilized Trypsin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Immobilized Trypsin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 2 ml
- 4 ml
- Others
Applications
- Academic & Research Institutes
- Pharmaceutical Companies
Companies covered
- Promega
- Thermo Scientific
- G-Biosciences
- SignalChem
- Takara
- GoldBio
- Creative Enzymes
- ProteoChem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Immobilized Trypsin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Immobilized Trypsin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Immobilized Trypsin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Immobilized Trypsin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Immobilized Trypsin Market Dynamics
- 2.1 Immobilized Trypsin Industry Trends
- 2.2 Immobilized Trypsin Industry Drivers
- 2.3 Immobilized Trypsin Industry Opportunities and Challenges
- 2.4 Immobilized Trypsin Industry Restraints
3 Immobilized Trypsin Market by Manufacturers
- 3.1 Global Immobilized Trypsin Revenue by Manufacturers (2021-2026)
- 3.2 Global Immobilized Trypsin Sales by Manufacturers (2021-2026)
- 3.3 Global Immobilized Trypsin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Immobilized Trypsin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Immobilized Trypsin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Immobilized Trypsin Manufacturers, Product Type & Application
- 3.7 Global Immobilized Trypsin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Immobilized Trypsin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Immobilized Trypsin Players Market Share by Revenue in 2025
- 3.8.3 2025 Immobilized Trypsin Tier 1, Tier 2, and Tier 3
4 Immobilized Trypsin Market by Type
- 4.1 Immobilized Trypsin Type Introduction
- 4.1.1 2 ml
- 4.1.2 4 ml
- 4.1.3 Others
- 4.2 Global Immobilized Trypsin Sales by Type
- 4.2.1 Global Immobilized Trypsin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Immobilized Trypsin Sales by Type (2021-2032)
- 4.2.3 Global Immobilized Trypsin Sales Market Share by Type (2021-2032)
- 4.3 Global Immobilized Trypsin Revenue by Type
- 4.3.1 Global Immobilized Trypsin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Immobilized Trypsin Revenue by Type (2021-2032)
- 4.3.3 Global Immobilized Trypsin Revenue Market Share by Type (2021-2032)
5 Immobilized Trypsin Market by Application
- 5.1 Immobilized Trypsin Application Introduction
- 5.1.1 Academic & Research Institutes
- 5.1.2 Pharmaceutical Companies
- 5.2 Global Immobilized Trypsin Sales by Application
- 5.2.1 Global Immobilized Trypsin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Immobilized Trypsin Sales by Application (2021-2032)
- 5.2.3 Global Immobilized Trypsin Sales Market Share by Application (2021-2032)
- 5.3 Global Immobilized Trypsin Revenue by Application
- 5.3.1 Global Immobilized Trypsin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Immobilized Trypsin Revenue by Application (2021-2032)
- 5.3.3 Global Immobilized Trypsin Revenue Market Share by Application (2021-2032)
6 Global Immobilized Trypsin Sales by Region
- 6.1 Global Immobilized Trypsin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Immobilized Trypsin Sales by Region (2021-2032)
- 6.2.1 Global Immobilized Trypsin Sales by Region (2021-2026)
- 6.2.2 Global Immobilized Trypsin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Immobilized Trypsin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Immobilized Trypsin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Immobilized Trypsin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Immobilized Trypsin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Immobilized Trypsin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Immobilized Trypsin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Immobilized Trypsin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Immobilized Trypsin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Immobilized Trypsin Revenue by Region
- 7.1 Global Immobilized Trypsin Revenue by Region
- 7.1.1 Global Immobilized Trypsin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Immobilized Trypsin Revenue by Region (2021-2026)
- 7.1.3 Global Immobilized Trypsin Revenue by Region (2027-2032)
- 7.1.4 Global Immobilized Trypsin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Immobilized Trypsin Revenue (2021-2032)
- 7.2.2 North America Immobilized Trypsin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Immobilized Trypsin Revenue (2021-2032)
- 7.3.2 Europe Immobilized Trypsin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Immobilized Trypsin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Immobilized Trypsin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Immobilized Trypsin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Immobilized Trypsin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Promega
- 8.1.1 Promega Company Information
- 8.1.2 Promega Business Overview
- 8.1.3 Promega Immobilized Trypsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Promega Immobilized Trypsin Product Portfolio
- 8.1.5 Promega Recent Developments
- 8.2 Thermo Scientific
- 8.2.1 Thermo Scientific Company Information
- 8.2.2 Thermo Scientific Business Overview
- 8.2.3 Thermo Scientific Immobilized Trypsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Scientific Immobilized Trypsin Product Portfolio
- 8.2.5 Thermo Scientific Recent Developments
- 8.3 G-Biosciences
- 8.3.1 G-Biosciences Company Information
- 8.3.2 G-Biosciences Business Overview
- 8.3.3 G-Biosciences Immobilized Trypsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 G-Biosciences Immobilized Trypsin Product Portfolio
- 8.3.5 G-Biosciences Recent Developments
- 8.4 SignalChem
- 8.4.1 SignalChem Company Information
- 8.4.2 SignalChem Business Overview
- 8.4.3 SignalChem Immobilized Trypsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 SignalChem Immobilized Trypsin Product Portfolio
- 8.4.5 SignalChem Recent Developments
- 8.5 Takara
- 8.5.1 Takara Company Information
- 8.5.2 Takara Business Overview
- 8.5.3 Takara Immobilized Trypsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Takara Immobilized Trypsin Product Portfolio
- 8.5.5 Takara Recent Developments
- 8.6 GoldBio
- 8.6.1 GoldBio Company Information
- 8.6.2 GoldBio Business Overview
- 8.6.3 GoldBio Immobilized Trypsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GoldBio Immobilized Trypsin Product Portfolio
- 8.6.5 GoldBio Recent Developments
- 8.7 Creative Enzymes
- 8.7.1 Creative Enzymes Company Information
- 8.7.2 Creative Enzymes Business Overview
- 8.7.3 Creative Enzymes Immobilized Trypsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Creative Enzymes Immobilized Trypsin Product Portfolio
- 8.7.5 Creative Enzymes Recent Developments
- 8.8 ProteoChem
- 8.8.1 ProteoChem Company Information
- 8.8.2 ProteoChem Business Overview
- 8.8.3 ProteoChem Immobilized Trypsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 ProteoChem Immobilized Trypsin Product Portfolio
- 8.8.5 ProteoChem Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Immobilized Trypsin Value Chain Analysis
- 9.1.1 Immobilized Trypsin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Immobilized Trypsin Production Mode & Process
- 9.2 Immobilized Trypsin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Immobilized Trypsin Distributors
- 9.2.3 Immobilized Trypsin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst